Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : a3541c9a-f17a-4be3-8e5f-372126fd
The current dominant strain of COVID-19 is three to six times as infectious as the original variation, a new study has suggested. The new strain is, however, not more severe. The variation of COVID-19 currently dominating global cases is more infectious than the original strain that emerged in China, according to a new study published…
A strain of the coronavirus that was first seen in Italy is now the dominant strain of the virus, a group of scientists said Thursday.In an article published by the peer-reviewed science journal Cell, researchers working with the Sheffield COVID-19 Genomics Group announced that the new strain "has become the most prevalent form in the global…
Pigs in their pen at a farm on the outskirts of Chengdu in China's south west Sichuan province, on August 2, 2005.Peter Parks | AFP | Getty ImagesScientists have identified a new strain of flu carried by pigs in China that they say has the potential to become a pandemic.The new strain is descended from…
I was officially diagnosed with Lupus in May of 2021. I say officially because my symptoms started long before that, I just didn't know it. Lupus is a chronic autoimmune disease that can cause inflammation and pain in different parts of the body. Your immune system is meant to help your body fight infection. But
Pros Has a sturdy, 11-gauge steel build Supports up to 500 pounds Costs less than $100 Cons Only comes with a straight bar Sticks out two feet from the wall We like the Titan Fitness Adjustable Depth Pull-Up Bar because it’s sturdy, bare-bones, and relatively affordable. The mounting is a touch more complicated than doorway-mounted
Duodenal mucosal resurfacing (DMR) — an investigational endoscopic procedure — helped patients maintain weight loss, and in some cases, even lose additional weight, 3 months after discontinuing GLP-1 receptor agonist therapy, initial results of the open-label, multistage REMAIN-1 trial showed. In addition, “the procedure was well tolerated, with only minor, transient TEAEs [treatment-emergent adverse events]